These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 9659795)
1. The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c. Sorsa T; Pollesello P; Solaro RJ Mol Cell Biochem; 2004 Nov; 266(1-2):87-107. PubMed ID: 15646030 [TBL] [Abstract][Full Text] [Related]
2. Effects of calcium sensitizers on intracellular calcium handling and myocardial energetics. Hasenfuss G; Pieske B; Kretschmann B; Holubarsch C; Alpert NR; Just H J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S45-51. PubMed ID: 8907130 [TBL] [Abstract][Full Text] [Related]
4. Effects of Ca2+ sensitizers on contraction, [Ca2+]i transient and myofilament Ca2+ sensitivity in diabetic rat myocardium: potential usefulness as inotropic agents. Ishitani T; Hattori Y; Sakuraya F; Onozuka H; Makino T; Matsuda N; Gando S; Kemmotsu O J Pharmacol Exp Ther; 2001 Aug; 298(2):613-22. PubMed ID: 11454923 [TBL] [Abstract][Full Text] [Related]
5. Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes. Sugawara H; Sakurai K; Atsumi H; Nakada S; Tomoike H; Endoh M J Card Fail; 2000 Dec; 6(4):338-49. PubMed ID: 11145759 [TBL] [Abstract][Full Text] [Related]
6. Calcium sensitizers in chronic heart failure: inotropic interventions-reservation to preservation. Teramura S; Yamakado T Cardiologia; 1998 Apr; 43(4):375-85. PubMed ID: 9659795 [TBL] [Abstract][Full Text] [Related]
7. Will calcium sensitizers play a role in the treatment of heart failure? Nielsen-Kudsk JE; Aldershvile J J Cardiovasc Pharmacol; 1995; 26 Suppl 1():S77-84. PubMed ID: 8907135 [TBL] [Abstract][Full Text] [Related]